jain.com

Merger with Core Scientific, Inc.

Company: CoreWeave

This claim was marked delayed on September 3, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
acquisition
Statement date
2025-07-06
Promised by
2026-04-07
Promised amount
0.1235 shares
Current status
delayed

The claim, verbatim

CoreWeave will acquire Core Scientific, Inc. through a merger in which each share of Core Scientific common stock will be converted into 0.1235 shares of CoreWeave Class A common stock.

Source (primary)

CoreWeave 8-K/A filed 2025-07-07 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “On July 7, 2025, Parent entered into an Agreement and Plan of Merger... each share of common stock of the Company... will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of Class A common stock of Parent”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms CoreWeave 8-K/A filed 2025-07-07

Quote: “On July 7, 2025, Parent entered into an Agreement and Plan of Merger... each share of common stock of the Company... will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of Class A common stock of Parent”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 2, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 3, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.